Tamar Elkeles - 17 Sep 2026 Form 4 Insider Report for PETMED EXPRESS INC (PETS)

Reporting relationship: Director
Issuer ticker: PETS
Reported as of: 17 Sep 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 21 Sep 2026, 08:58:47 UTC
Prior SEC filing: 06 Aug 2026
Source filing: View source filing
Reporting owner signature: /s/ Tamar Elkeles

Key filing fact

Tamar Elkeles filed Form 4 for PETMED EXPRESS INC (PETS) on 21 Sep 2026.

Key facts

This page summarizes Tamar Elkeles's Form 4 filing for PETMED EXPRESS INC (PETS).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 21 Sep 2026, 08:58.

Change

Previous filing in this sequence was filed on 06 Aug 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001750083 Primary reporting owner

Elkeles Tamar

Relationship: Director
Address: C/O PETMED EXPRESS, INC., 420 SOUTH CONGRESS AVENUE, DELRAY BEACH
Signature: /s/ Tamar Elkeles
Signature date: 21 Sep 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

PETS transaction

Common Stock

Award

Transaction value
Shares: +49,923
Change %
Price: $0.000000^*
Shares after: 49,923
Date: 17 Sep 2026
Ownership: Direct
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Consists of a restricted stock award made pursuant to the PetMed Express, Inc. 2024 Omnibus Incentive Plan which will vest in its entirety on September 17, 2027, subject to continued service on the Board of Directors.